𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoamine oxidase inhibition by the MAO-A inhibitors brofaromine and clorgyline in healthy volunteers

✍ Scribed by C. H. Gleiter; B. Mühlbauer; R. M. Schulz; E. Nilsson; K. H. Antonin; P. R. Bieck

Publisher
Springer
Year
1994
Tongue
English
Weight
294 KB
Volume
95
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of food on the disposition of
Influence of food on the disposition of the monoamine oxidase-A inhibitor brofaromine in healthy volunteers
✍ Dr P. H. Degen; J. M. Cardot; C. Czendlik; W. Dieterle 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 2 views

ty of brolxomine hyr!rocfiioride was investigated t healthy male volunteers were g i x n Tingle peroral r 'hy'rochloride after overnight fasting or a fpt-a:d proteiniich breakfast Mean ( : b SL)) areas under the plasma concentration-time curves (AUC) were 9 -5 6 (2\*j5)prm11 h when g i e n to he fas

Fenfluramine-induced suppression of food
Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline
✍ C. S. Aulakh; J. L. Hill; K. M. Wozniak; D. L. Murphy 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 565 KB

Administration of fenfluramine to rats produced decreases in 1-h food intake and locomotor activity. Short-term (2-6 days) or long-term (21-25 days) treatment with the monoamine oxidase (MAO) type A inhibiting antidepressant clorgyline potentiated fenfluramine-induced suppression of food intake but

Inhibition of sucrose- and starch-induce
Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the α-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers
✍ B. Lembcke; U. R. Fölsch; W. Gatzemeier; B. Lücke; R. Ebert; E. Siegel; W. Creut 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 706 KB

The absorbable deoxynojirimycin derivative emiglitate (BAY o 1248) is a potent competitive inhibitor of small intestinal alpha-glucosidases in man. In two similar randomized, placebo-controlled, double blind investigations, the efficacy, duration of action and tolerability of single doses of 10, 20